Table 3 Incidence per 100,000 person years (p-yrs) at risk for developing incident gout in men and women by different levels of SU at baseline screening
No of individuals by sex and s-UA | SU at baseline (μmol/L) | Incident gout (n) | Person-years at risk | Incidence (95% CI) per 100,000 person-years at risk | Absolute risk (%)* |
|---|---|---|---|---|---|
Men (n = 22,368) | |||||
16,824 | ≤360 | 447 | 493,612 | 90 (82.2–99) | 2.7 (2.4–2.9) |
3353 | 361–405 | 227 | 95,408 | 238 (208.5–270.5) | 6.8 (6.0–7.7) |
2191 | > 405 | 292 | 58,094 | 527.4 (471.4–588.1) | 13.3 (12.0–14.8) |
Women (n = 10,902) | |||||
10,357 | ≤ 360 | 200 | 278,493 | 70.6 (61.2–81.1) | 1.9 (1.7–2.2) |
327 | 361–405 | 25 | 7655 | 340.9 (224.6–496) | 7.6 (5.1–10.9) |
164 | > 405 | 29 | 3564 | 828.6 (566.7–1170) | 17.7 (12.4–24.6) |